Alexandria Real Estate Equities, Inc. reports news as a life science real estate investment trust that owns, operates and develops collaborative Megacampus™ ecosystems in major life science innovation clusters. Company updates commonly cover operating results, funds from operations, leasing activity, rental-rate trends and property-market demand across locations such as Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City.
Recurring announcements also include quarterly common stock dividends, balance-sheet and liquidity commentary, capital recycling activity, senior note offerings, cash tender offers for outstanding debt and corporate governance or leadership matters tied to the REIT’s public-company structure.
On February 2, 2022, Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced the pricing of a public offering of $800 million in 2.950% senior notes due 2034 and $1 billion in 3.550% senior notes due 2052. The notes are unsecured and will be guaranteed by Alexandria Real Estate Equities, L.P. Proceeds from the 2034 notes will initially support general corporate purposes and fund eligible green projects. The 2052 notes will be used for general working capital, including the repayment of a secured note totaling $196.5 million. Closing is expected on February 16, 2022.
Alexandria Real Estate Equities, Inc. (NYSE: ARE) has announced an underwritten public offering of senior notes, subject to market conditions. The offering consists of two tranches, with net proceeds from the first tranche intended for general corporate purposes, including debt reduction and funding green projects with LEED certification. The second tranche will also support general working capital and corporate expenses. The offering is conducted under an effective Form S-3 registration statement.
Alexandria Real Estate Equities (ARE) reported strong financial results for Q4 2021, with total revenues of $576.9 million, a 24.4% increase year-over-year. Net income for the quarter was $72.8 million, down from $435.9 million in Q4 2020. Funds from operations rose to $303.6 million, reflecting a per-share increase to $1.97. The company achieved historic leasing volumes, with a total of 4 million RSF leased in Q4 2021. Operating income increased 24.2% year-over-year, and the dividend was raised to $1.15 per share. Alexandria's liquidity stands at $5.4 billion.
Summary not available.
Alexandria Real Estate Equities (NYSE: ARE) announced the tax treatment for its 2021 distributions, detailing the composition of dividends, capital gains, and return of capital. The report urges stockholders to consult tax advisors regarding their specific tax implications. The distributions per share include $4.420000 total with various components classified under ordinary dividends, capital gains, and return of capital, highlighting a significant portion classified as qualified dividends. The record and payment dates for distributions are also specified.
On January 18, 2022, Alexandria Real Estate Equities (NYSE: ARE) announced the full exercise of an underwriter's option to purchase an additional 1,050,000 shares at $210.00 each, increasing its public offering to 8,050,000 shares. The proceeds from future settlements of the forward sale agreements will fund acquisitions and construction projects. The offering will allow Alexandria to delay the issuance of shares while managing capital needs. No immediate proceeds will be received from this sale.
On January 10, 2022, Alexandria Venture Investments announced its recognition as the top corporate investor in biopharma for new deal volume for the fifth consecutive year, according to Silicon Valley Bank's 2022 report. This accolade underscores Alexandria's commitment to enhancing human health through significant investments in the life sciences sector. The company has generated over 10x returns for various portfolio companies since its inception in 1996. Alexandria's market capitalization stands at $38.6 billion, with large investments in urban life science and technology campuses, reflecting its strategic focus on key innovation areas.
On January 7, 2022, Alexandria Real Estate Equities (NYSE: ARE) announced the closing of a public offering of 7,000,000 shares at $210.00 per share. The offering involved forward sale agreements with major banks including JPMorgan and Bank of America. While the company will not receive initial proceeds from the shares sold by forward purchasers, future proceeds will be allocated towards acquisitions, development projects, and general corporate purposes. Alexandria, recognized for its focus on collaborative life science and technology campuses, continues to establish a significant market presence in key U.S. locations.
On January 4, 2022, Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced its upsized public offering of 7,000,000 shares of common stock priced at $210.00 per share. The offering includes a 30-day option for underwriters to purchase an additional 1,050,000 shares. The offering's expected closing date is on or about January 7, 2022. The proceeds, if any, from future settlements of forward sale agreements are planned to fund acquisitions and development projects, as well as general corporate purposes.
Alexandria Real Estate Equities (NYSE: ARE) announced a public offering of 6,500,000 shares of its common stock, with a potential 30-day option for underwriters to buy an additional 975,000 shares. The financing aims to support pending acquisitions and fund development projects. The company will not initially receive proceeds from the sale, as the forward purchasers will first sell these shares to underwriters. Settlement of the forward sale agreements is expected by September 15, 2023.